ARCHIVES

PDX Shows 27% Response In T-Cell Lymphoma In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy

September 27, 2013

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

NEW OIG Awards Bring Total to 58

November 13, 1987

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984